EMA: Considers administering the Moderna vaccine to children under 5 years of age

The European Medicines Agency (EMA) announced today that it has begun evaluating the use of the Moderna vaccine against Covid-19 in children aged six months to 5 years, the last age group that cannot yet be vaccinated.

“We have just begun evaluating a request from Moderna to extend the use of Spikevax to children aged six months to 5 years and it is the first request for this new age group,” Marco Cavaleri, head of the department, told a news conference. strategy for EMA vaccines.

The American biotechnology company Moderna already made a similar request in the US last week after tests showed that these vaccines are safe and produce a strong immune response.

Young children are less vulnerable to the virus than older people, but they can still get sick and transmit the virus.

Severe forms of multisystem inflammatory bowel syndrome (MIS-C) can also occur in children.

Coreper approved in February the use of the Moderna Covid vaccine for children aged six and over in the 27 member states of the European Union.

Source: ΑΠΕ-ΜΠΕ

Source: Capital

You may also like